ACKR3 and lymphoma: On the other hand, it was shown that both CXCR4 and CXCR7 responded to CXCL12 to greatly increase human lymphoma cells’ migration, indicating that CXCR7 might be an efficient target for cancer treatment (Zabel et al., 2011).